Terms: = Liver cancer AND TCF7L2, ENSG00000148737, 6934, TCF-4 AND Treatment
8 results:
1. [Genes and molecular mechanisms affecting the correlation between liver cancer and diabetes mellitus].
Yang Y; Zhang BH; Gong JP
Zhonghua Gan Zang Bing Za Zhi; 2018 Sep; 26(9):718-720. PubMed ID: 30481877
[TBL] [Abstract] [Full Text] [Related]
2. Upregulated microRNA-429 inhibits the migration of HCC cells by targeting TRAF6 through the NF-κB pathway.
Wang P; Cao J; Liu S; Pan H; Liu X; Sui A; Wang L; Yao R; Liu Z; Liang J
Oncol Rep; 2017 May; 37(5):2883-2890. PubMed ID: 28440423
[TBL] [Abstract] [Full Text] [Related]
3. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast cancers and Their Metastases.
Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
[No Abstract] [Full Text] [Related]
4. tcf7l2 involvement in estradiol- and progesterone-modulated islet and hepatic glucose homeostasis.
Dong F; Ling Q; Ye D; Zhang Z; Shu J; Chen G; Fei Y; Li C
Sci Rep; 2016 Apr; 6():24859. PubMed ID: 27108846
[TBL] [Abstract] [Full Text] [Related]
5. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/tcf-4 pathway.
Gu W; Li X; Wang J
Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507
[TBL] [Abstract] [Full Text] [Related]
6. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
Yamashita T; Budhu A; Forgues M; Wang XW
Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
[TBL] [Abstract] [Full Text] [Related]
7. Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling.
Du Q; Park KS; Guo Z; He P; Nagashima M; Shao L; Sahai R; Geller DA; Hussain SP
Cancer Res; 2006 Jul; 66(14):7024-31. PubMed ID: 16849547
[TBL] [Abstract] [Full Text] [Related]
8. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.
Sekiya T; Nakamura T; Kazuki Y; Oshimura M; Kohu K; Tago K; Ohwada S; Akiyama T
Cancer Res; 2002 Jun; 62(11):3322-6. PubMed ID: 12036951
[TBL] [Abstract] [Full Text] [Related]
